128 related articles for article (PubMed ID: 2848823)
21. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
Elgavish A; Pillion DJ; Meezan E
Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697
[TBL] [Abstract][Full Text] [Related]
22. Limited proteolysis of the vasoactive intestinal peptide receptor: comparison of its folded structure in the membrane-bound and detergent-solubilized states.
Provow SA; Veliçelebi G
Regul Pept; 1990 Mar; 28(1):71-82. PubMed ID: 2158128
[TBL] [Abstract][Full Text] [Related]
23. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
25. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
26. High affinity peptide histidine isoleucine-preferring receptors in rat liver.
Paul S; Chou J; Kubota E
Life Sci; 1987 Nov; 41(21):2373-80. PubMed ID: 2824950
[TBL] [Abstract][Full Text] [Related]
27. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of VIP receptors in human lung membranes.
Robberecht P; Waelbroeck M; de Neef P; Camus JC; Coy DH; Christophe J
Peptides; 1988; 9(2):339-45. PubMed ID: 2836826
[TBL] [Abstract][Full Text] [Related]
29. PACAP and VIP receptors in rat liver membranes.
Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
[TBL] [Abstract][Full Text] [Related]
30. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
Wanke IE; Rorstad OP
Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
[TBL] [Abstract][Full Text] [Related]
31. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
33. VIP receptors in mesenteric and coronary arteries: a radioligand binding study.
Huang M; Rorstad OP
Peptides; 1987; 8(3):477-85. PubMed ID: 2821520
[TBL] [Abstract][Full Text] [Related]
34. Characterization and localization of vasoactive intestinal peptide receptors in the rat lung.
Leroux P; Vaudry H; Fournier A; St-Pierre S; Pelletier G
Endocrinology; 1984 May; 114(5):1506-12. PubMed ID: 6325122
[TBL] [Abstract][Full Text] [Related]
35. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.
Segura JJ; Guerrero JM; Goberna R; Calvo JR
Regul Pept; 1991 Apr; 33(2):133-43. PubMed ID: 1652777
[TBL] [Abstract][Full Text] [Related]
36. Interaction of a bovine thymic peptide extract with vasoactive intestinal peptide (VIP) receptors.
Guerrero JM; Goberna R; Molinero P; Jimenez J; Calvo JR
Biosci Rep; 1986 Jun; 6(6):579-84. PubMed ID: 3021253
[TBL] [Abstract][Full Text] [Related]
37. Structural characterization of vasoactive intestinal peptide receptors from rat lung membranes.
Veliçelebi G; Patthi S; Provow S; Akong M; Simerson S
Ann N Y Acad Sci; 1988; 527():266-81. PubMed ID: 2839081
[No Abstract] [Full Text] [Related]
38. Isolation of a low molecular mass vasoactive intestinal peptide binding protein.
Brugger CH; Stallwood D; Paul S
J Biol Chem; 1991 Sep; 266(27):18358-62. PubMed ID: 1655745
[TBL] [Abstract][Full Text] [Related]
39. Purification of vasoactive intestinal peptide receptor from porcine liver by a newly designed one-step affinity chromatography.
Couvineau A; Voisin T; Guijarro L; Laburthe M
J Biol Chem; 1990 Aug; 265(22):13386-90. PubMed ID: 2165502
[TBL] [Abstract][Full Text] [Related]
40. Binding and degradation of vasoactive intestinal peptide in prolactin-producing cultured rat pituitary tumour cells (GH4C1).
Bjøro T; Wiik P; Opstad PK; Gautvik KM; Haug E
Acta Physiol Scand; 1987 Aug; 130(4):609-18. PubMed ID: 2820199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]